{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-003887","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2025-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.173995+00:00","generated_at":"2026-05-23T16:00:13.152635+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nasdaq grants Daré extension until Aug 12, 2025 to regain listing compliance","bullets":["Extension conditional on meeting stockholders' equity >$2.5M by April 30, 2025 and further increase by July 15, 2025.","Company must publicly disclose equity-raising transactions and provide 12-month projections by August 12, 2025.","Non-compliance with Nasdaq Rule 5550(b) since August 2024; risk of delisting if conditions not met.","Panel may reconsider extension or delist after April 30 if plan execution falters."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-003887","json":"https://secwatch.observer/filing/0001641172-25-003887.json","markdown":"https://secwatch.observer/filing/0001641172-25-003887.md","text":"https://secwatch.observer/filing/0001641172-25-003887.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000164117225003887/0001641172-25-003887-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000164117225003887/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T16:00:13.152635+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}